Incidence of Postoperative Nausea and Vomiting in Patient Undergoing Sleeve Surgery with BMI > 35 Maintained with Isoflurane
Main Article Content
Keywords
BMI, isoflurane, nausea and vomiting, sleeve surgery
Abstract
Background and aim: Patients with a body mass index (BMI) of 35 or above undergoing sleeve surgery under isoflurane anesthesia will be analyzed for their risk of experiencing postoperative nausea and vomiting (PONV). Isoflurane is a popular anesthetic used during sleeve surgery, and postoperative nausea and vomiting (PONV) is a typical consequence. The purpose of this study is to collect data on the frequency with which patients who have had sleeve gastrectomy experienced postoperative nausea and vomiting.
Material and method: In a prospective descriptive analysis, 55 patients who matched the inclusion criteria were randomly assigned to one of two groups using a non-randomized allocation approach. Blood pressure, end-tidal CO2, oxygen saturation, and heart rate were all measured and tracked for each patient. A consistent method of evaluating the frequency and severity of nausea and vomiting was used. Eligibility criteria included having a body mass index (BMI) over 35, being between the ages of 19 and 45, and having chosen to have gastric sleeve surgery as an elective procedure. Women with a body mass index (BMI) lower than 35 or pregnant were not eligible. The researchers determined that a sample size of n = 55 was appropriate. Convenience sampling was used to pick the participants. The research made that the sample was representative and that the sampling strategy could be implemented as planned.
Results: Age, sex, body mass index, length of operation, antiemetic medicine, smoking, nausea and vomiting history, and premedication are all factors that are analyzed. The study concludes that the two groups, those who experience and those who do not, differ significantly in terms of mean operation length, antiemetic drug use, and history of nausea and vomiting following surgery.There is no statistically significant difference in demographics such as age, gender, body mass index, smoking status, or premedication usage.
Conclusion: The objective of this study was to utilize logistic regression analysis to identify risk factors associated with postoperative nausea and vomiting (PONV). The findings revealed an inverse relationship between age and the incidence of PONV, while smoking was positively associated with PONV. The use of antiemetic medication, a higher body mass index (BMI), and longer surgical duration were also found to be correlated with an increased risk of PONV. However, there were no statistically significant correlations observed between preoperative treatment with Dexamethasone or ondansetron, gender, and the occurrence of PONV. Based on these results, the researchers concluded that these factors should be taken into consideration when assessing a patient's risk of experiencing postoperative nausea and vomiting during surgery.
References
2. Besir A, Tugcugil EJJoO, Gynaecology. Comparison of different end-tidal carbon dioxide levels in preventing postoperative nausea and vomiting in gynaecological patients undergoing laparoscopic surgery. 2021;41(5):755-62.
3. Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. 2019;131(2):411-48.
4. Fox G, Kranke PJErocp. A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting. 2020;13(4):331-40.
5. Karaman S, Karaman T, Tapar H, Dogru S, Suren MJCtim. A randomized placebo-controlled study of aromatherapy for the treatment of postoperative nausea and vomiting. 2019;42:417-21.
6. Franco JVA, Ruiz PA, Palermo M, Gagner MJOs. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. 2011;21:1458-68.
7. Soltan WA, Fathy E, Khattab M, Mostafa MS, Hasan H, Refaat A, et al. Combined thoracic spinal-epidural anesthesia for laparoscopic sleevegastrectomy; one hundred case experience. 2022:1-6.
8. Ma Y, Fan Y, Zhou D, Chen J, Ge SJP. Laparoscopic sleeve gastrectomy under general anesthesia in severely obese patients: a single-centered retrospective study. 2021;9:e10802.
9. Srivastava G, Buffington CJOs. A specialized medical management program to address post-operative weight regain in bariatric patients. 2018;28:2241-6.
10. Hall DM, Cole TJJAodic. What use is the BMI? 2006;91(4):283-6.
11. Nuttall FQJNt. Body mass index: obesity, BMI, and health: a critical review. 2015;50(3):117.
12. Chooi YC, Ding C, Magkos FJM. The epidemiology of obesity. 2019;92:6-10.
13. Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, et al. Obesity and severe obesity forecasts through 2030. 2012;42(6):563-70.
14. Eger 2nd EI. The pharmacology of isoflurane. British journal of anaesthesia. 1984 Jan 1;56:71S-99S.
15. Yang CF, Chen MY, Chen TI, Cheng CF. Dose-dependent effects of isoflurane on cardiovascular function in rats. Tzu Chi Medical Journal. 2014 Sep 1;26(3):119-22.
16. Pokhrel LR, Grady KD. Risk assessment of occupational exposure to anesthesia Isoflurane in the hospital and veterinary settings. Science of The Total Environment. 2021 Aug 20;783:146894.
17. Cao X, White PF, Ma H. An update on the management of postoperative nausea and vomiting. Journal of anesthesia. 2017 Aug;31:617-26.
18. George RB, Allen TK, Habib ASJA, Analgesia. Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis. 2009;109(1):174-82.
19. Rose J, Watcha MJBjoa. Postoperative nausea and vomiting in paediatric patients. 1999;83(1):104-17.
20. Kovac ALJD. Prevention and treatment of postoperative nausea and vomiting. 2000;59:213-43.
21. Ho C-M, Wu H-L, Ho S-T, Wang J-JJAAT. Dexamethasone prevents postoperative nausea and vomiting: benefit versus risk. 2011;49(3):100-4.